[go: up one dir, main page]

MX2008007808A - Analogos de rifamicina y usos de ellos. - Google Patents

Analogos de rifamicina y usos de ellos.

Info

Publication number
MX2008007808A
MX2008007808A MX2008007808A MX2008007808A MX2008007808A MX 2008007808 A MX2008007808 A MX 2008007808A MX 2008007808 A MX2008007808 A MX 2008007808A MX 2008007808 A MX2008007808 A MX 2008007808A MX 2008007808 A MX2008007808 A MX 2008007808A
Authority
MX
Mexico
Prior art keywords
rifamycin analogs
analogs
rifamycin
treat
compounds
Prior art date
Application number
MX2008007808A
Other languages
English (en)
Inventor
John H Van Duzer
Arthur F Michaelis
William B Geiss
Douglas G Stafford
Joseph Raker
Xiang Y Yu
James M Siedlecki
Yingfei Yang
Original Assignee
Activbiotics Pharma Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Activbiotics Pharma Llc filed Critical Activbiotics Pharma Llc
Publication of MX2008007808A publication Critical patent/MX2008007808A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La presente invención comprende análogos de rifamicina y métodos para usar estos compuestos para tratar una variedad de infecciones microbianas.
MX2008007808A 2005-12-14 2006-12-14 Analogos de rifamicina y usos de ellos. MX2008007808A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75090205P 2005-12-14 2005-12-14
PCT/US2006/047648 WO2007070613A2 (en) 2005-12-14 2006-12-14 Rifamycin analogs and uses thereof

Publications (1)

Publication Number Publication Date
MX2008007808A true MX2008007808A (es) 2008-09-15

Family

ID=38163512

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008007808A MX2008007808A (es) 2005-12-14 2006-12-14 Analogos de rifamicina y usos de ellos.

Country Status (8)

Country Link
US (1) US7547692B2 (es)
EP (1) EP1968600A4 (es)
CN (1) CN101395259A (es)
AU (1) AU2006326456A1 (es)
BR (1) BRPI0620158A2 (es)
CA (1) CA2632028A1 (es)
MX (1) MX2008007808A (es)
WO (1) WO2007070613A2 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7838532B2 (en) * 2005-05-18 2010-11-23 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US8524735B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US7884099B2 (en) 2007-11-16 2011-02-08 Cumbre Ip Ventures, L.P. Quinolone carboxylic acid-substituted rifamycin derivatives
WO2009142719A2 (en) * 2008-05-19 2009-11-26 Massachusetts Institute Of Technology Tympanic membrane permeating ear drops and uses thereof
CA2739893C (en) 2008-10-07 2016-10-04 Mpex Pharmaceuticals, Inc. Inhalation of levofloxacin for reducing lung inflammation
US8815838B2 (en) 2008-10-07 2014-08-26 David C. Griffith Aerosol fluoroquinolone formulations for improved pharmacokinetics
EP3569235A1 (en) 2009-09-04 2019-11-20 Horizon Orphan LLC Use of aerosolized levofloxacin for treating cystic fibrosis
WO2014147578A2 (en) * 2013-03-20 2014-09-25 Department Of Biotechnology Antibacterial compounds against drug resistant bacteria
MX369022B (es) 2013-05-31 2019-10-25 Genentech Inc Anticuerpos anti-ácido teicoico de la pared celular y conjugados.
US9884126B2 (en) 2013-05-31 2018-02-06 Genentech, Inc. Anti-wall teichoic antibodies and conjugates
US9803002B2 (en) 2013-05-31 2017-10-31 Genentench, Inc. Anti-wall teichoic antibodies and conjugates
MX2017007231A (es) 2014-12-03 2017-11-08 Genentech Inc Conjugados de rifamicina y anticuerpos contra el staphylococcuss aureus y usos de estos.
WO2016090038A1 (en) 2014-12-03 2016-06-09 Genentech, Inc. Anti-staphylococcus aureus antibody rifamycin conjugates and uses thereof
EP3331547A4 (en) 2015-08-05 2019-08-21 Children's Medical Center Corporation COMPOSITIONS WITH PERMEATION PROMOTERS FOR ACTIVE INJECTION
WO2017152083A1 (en) 2016-03-04 2017-09-08 Genentech, Inc. Process for the preparation of an antibody-rifamycin conjugate
WO2021189444A1 (zh) * 2020-03-24 2021-09-30 中国人民解放军海军军医大学 利福霉素类抗生素在制备抗黄热病毒感染药物中的应用
CN111317733B (zh) * 2020-03-24 2022-07-12 中国人民解放军海军军医大学 利福霉素类抗生素在制备抗黄热病毒感染药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4690919A (en) * 1984-01-04 1987-09-01 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Benzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same
JPS62263182A (ja) * 1986-05-06 1987-11-16 Kanegafuchi Chem Ind Co Ltd Ｎ−アルキルベンゾピラジノリフアマイシン誘導体
JPS6330490A (ja) * 1986-07-23 1988-02-09 Kanegafuchi Chem Ind Co Ltd アミノベンゾキサジノリフアマイシン誘導体
ES2088870T3 (es) 1988-03-18 1996-10-01 Kanegafuchi Chemical Ind Un derivado de benzoxazinorrifamicina sustituida, un procedimiento para preparar el mismo y un agente antibacteriano que contiene el mismo.
CN1894259A (zh) 2003-08-22 2007-01-10 活跃生物工艺学公司 利福霉素类似物及其应用
JP2007513961A (ja) 2003-12-10 2007-05-31 アクティブバイオティクス インコーポレイティッド リファマイシンアナログおよびその使用法
CN1918172B (zh) * 2003-12-23 2011-09-14 活跃生物工艺学公司 利福霉素类似物及其用途

Also Published As

Publication number Publication date
EP1968600A2 (en) 2008-09-17
CA2632028A1 (en) 2007-06-21
WO2007070613A2 (en) 2007-06-21
CN101395259A (zh) 2009-03-25
US7547692B2 (en) 2009-06-16
BRPI0620158A2 (pt) 2012-04-24
EP1968600A4 (en) 2009-07-15
US20070155715A1 (en) 2007-07-05
AU2006326456A1 (en) 2007-06-21
WO2007070613A3 (en) 2008-12-04

Similar Documents

Publication Publication Date Title
MX2009006536A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
HUE040060T2 (hu) Halogén-szubsztituált boronftalidok fertõzések kezelésére
MY153915A (en) Organic compounds
MX2009006846A (es) Derivados de tetraciclina para el tratamiento de infecciones bacterianas, virales y parasitarias.
MX360301B (es) Moleculas pequeñas que contienen boro como agentes antiinflamatorios.
MX2008007808A (es) Analogos de rifamicina y usos de ellos.
TW200626068A (en) Active compounds for seed treatment
MX2010006738A (es) Inhibidores de proteasa del virus de la hepatitis c (hcv) y usos de los mismos.
MX2010006736A (es) Inhibidores de proteasa del virus de la hepatitis c (hcv) y usos de los mismos.
TNSN08400A1 (en) Organic compounds and their uses
IN2014CN03629A (es)
WO2007115821A3 (en) Organic compounds
WO2007097981A3 (en) Alpha carbolines and uses thereof
PH12013502194A1 (en) Antibodies to egfl7 and methods for their use
TW200630367A (en) Substituted adenines and the uses thereof
TNSN08496A1 (en) Aminothiazoles and their uses
GB0613208D0 (en) Compounds
TW200700064A (en) Novel compounds
MX2008011576A (es) Compuestos de imidazo[2,1-b]tiazol sustituidos y su uso para la produccion de farmacos.
TW200744567A (en) Phenylethylamine analogs and their use for treating glaucoma
TW200700071A (en) Novel use
GB0513096D0 (en) Treatment of microbial infections
MX2009013214A (es) Macrociclos y sus usos.
EA200971067A1 (ru) Триазолиламинопиримидиновые соединения
TW200833343A (en) Novel therapeutic utilization for the treatment of leukaemias